Evidence map›Paper›PMID 34853140›Full record

ArticleSaudi medical journal2021

Post-vaccination survey for monitoring the side effects associated with COVID-19 vaccines among healthcare professionals of Jazan province, Saudi Arabia.

Waquar Ahsan, Nabeel K Syed, Aseel A Alsraeya, Hassan A Alhazmi, Asim Najmi, Mohammed Al Bratty, Shamama Javed, Hafiz A Makeen, Abdulkarim M Meraya, Ahmed A Albarraq and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Saudi medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Assessment of knowledge and awareness about ovarian cancer and its risk factors among women in Jazan, Saudi Arabia: a cross-sectional study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  3. Article
  4. Scrutinizing the COVID-19 vaccine safety debate.Human vaccines & immunotherapeutics · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Waquar AhsanFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Nabeel K SyedFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Aseel A AlsraeyaFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Hassan A AlhazmiFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Asim NajmiFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Mohammed Al BrattyFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Shamama JavedFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Hafiz A MakeenFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Abdulkarim M MerayaFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Ahmed A AlbarraqFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
Saad S AlqahtaniFrom the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia.
American Association of Colleges of Pharmacy · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify the self-reported vaccine-related side effects among healthcare professionals (HCPs) in the Jazan province, Saudi Arabia, and determine the associated socio-demographic factors. With the recent second and third waves of coronavirus disease -19 (COVID-19) infections worldwide, the race is not only to encourage but also to achieve mass vaccination.

methodsA total of 397 HCPs from across Jazan province participated in an anonymous online cross-sectional survey conducted for a period of 45 days (March 30, 2021 to May 13, 2021) in Jazan province, Saudi Arabia. Data was collected using a validated 22-items self-report survey.

resultsFor both COVID-19 vaccines, majority of reports were related to flu-like symptoms including fever, chills, headache, fatigue, tiredness, and myalgia. Statistically significant associations were observed between the severity of side effects and gender (χ

conclusionThe findings of the present study would help in designing educational programs aimed at combating the misconstrued fear of vaccination and highlighting the urgent need of getting vaccinated. This study also helps in the identification of factors affecting the presence and severity of side effects.

Indexed as

COVID-19COVID-19 VaccinesCross-Sectional StudiesDelivery of Health CareFemaleHumansMaleSARS-CoV-2Saudi ArabiaVaccinationCOVID-19 VaccinesAstraZenecaCOVID-19 vaccinationscovishieldPfizer-BioNTechSaudi Arabiaside effects

Identifiers

PMID34853140
PMCPMC9149761
OpenAlexW3216817845

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.